[August 09, 2016]

Global Enteric Disease Testing Market 2016-2020 - Key Vendors are Alere, bioMrieux, Cepheid & DiaSorin - Research and Markets

Research and Markets has announced the addition of the "Global Enteric Disease Testing Market 2016-2020" report to their offering.

The global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, the author uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus)

The development of novel NAAT for enteric disease testing is an important trend that will lead to the growth of this market. Currently, PCR (News - Alert) represents the gold standard for nucleic acid-based diagnostics. However, the need for variations in temperature increases power consumption and costs for laboratories. Currently, life sciences companies and academics have developed an isothermal amplification-based diagnostic method to circumvent the need for thermocyclers. Isothermal-based methods incorporate all the temperature-dependent steps of PCR by incorporating enzymes.

According to the report, high incidence of eneric diseases is one of the key drivers to augment the growth prospects for this market. Enteric diseases are the most common cause of mortality worldwide, after cardiovascular and respiratory diseases. There has been a rise in the incidence of enteric diseases globally over the past decade. For example, each year two billion cases of diarrhea are reported worldwide, and 760,000 children aged five of below succumb to the disease in Sub-Saharan Africa region. The high incidence of enteric diseases increases the demand for screening and testing of infected victims. This, in turn, drives the adoption of diagnostic tests, thereby contributing to market growth.

Further, the report states that stringent regulatory environment are hampering the growth of the market. The regulatory requirements for in vitro diagnostic (IVD) devices worldwide are specific and call for the provision of in-depth technical information, as most of them are classified as class III medical devices.

Key vendors

- Alere

- bioMérieux

- Cepheid

- DiaSorin

Other prominent vendors

- BD

- Biomerica

- Coris BioConcept

- Meridian Bioscience

- Mobidiag

- Quidel

- Quest Diagnostics

- R-Biopharm

- Trinity Biotech

- Thermo Fisher Scientific

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Reimbursement scenario: An overview

Part 06: Market landscape

Part 07: Types of clinical diagnostic testing

Part 08: Market segmentation by disease type

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Appendix

For more information visit http://www.researchandmarkets.com/research/v7jwcx/global_enteric

View source version on businesswire.com: http://www.businesswire.com/news/home/20160809006006/en/

[ Back To TMCnet.com's Homepage ]